article thumbnail

Economist Impact: World Cancer Series – pharmaphorum in attendance, day one (part ii)

pharmaphorum

Elliott informed those in attendance that for the next five years, with about £5 billion in funding for pipelines across a network of research and institute centres in clinical trials, that the aim is for everyone to live a life free of cancer. And in the UK over 30% of clinical trials funded has one European partner at least.

Nurses 97